Jeffrey Wolf, MD

Hematologist

Dr. Jeffrey L. Wolf is an expert in cancer of the bone marrow and blood as well as an expert in bone marrow transplantation to treat these cancers. His primary area of clinical expertise and research is myeloma, the second most common cancer of the blood. He is the director of the Multiple Myeloma Program and the Grand Multiple Myeloma Translational Initiative at the UCSF Helen Diller Family Comprehensive Cancer Center.

Wolf earned a medical degree at the University of Illinois in Chicago and completed a residency in medicine at the University of California in San Diego. He completed a hematology and oncology fellowship at UCSF and a bone marrow transplantation rotation at the Fred Hutchinson Cancer Center in Seattle. He helped establish the bone marrow transplant program at the City of Hope National Medical Center in Duarte, Calif. in 1979 and the first community-hospital-based bone marrow transplant unit at Alta Bates Medical Center in Berkeley in 1984. Wolf, who joined the UCSF Division of Hematology and Oncology in February 2007, is a clinical professor of medicine at UCSF.

Clinics

Hematology and Blood and Marrow Transplant
400 Parnassus Ave., Fourth Floor
San Francisco, CA 94143
Existing Patients: (415) 353-2421
New Patients: (415) 353-2051
Fax: (415) 353-2467

Hours: Monday to Friday, 8 a.m. - 5 p.m

Conditions & Treatments

Academic Title

Professor

More about Jeffrey Wolf

Education

University of Illinois College of Medicine 1972

Residencies

UC San Diego Medical Center, 1976

Fellowships

UCSF Medical Center, Hematology-Oncology 1979

Selected Research and Publications

  1. Le Moigne R, Aftab BT, Djakovic S, Dhimolea E, Valle E, Murnane M, King EM, Soriano F, Menon MK, Wu ZY, Wong ST, Lee GJ, Yao B, Wiita AP, Lam C, Rice J, Wang J, Chesi M, Bergsagel PL, Kraus M, Driessen C, Kiss von Soly S, Yakes FM, Wustrow D, Shawver L, Zhou HJ, Martin TG, Wolf JL, Mitsiades CS, Anderson DJ, Rolfe M. The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma. Mol Cancer Ther. 2017 11; 16(11):2375-2386.
  2. Le TX, Wolf JL, Peralta CA, Webber AB. Kidney Transplantation for Kidney Failure Due to Multiple Myeloma: Case Reports. Am J Kidney Dis. 2017 Jun; 69(6):858-862.
  3. Sherbenou DW, Aftab BT, Su Y, Behrens CR, Wiita A, Logan AC, Acosta-Alvear D, Hann BC, Walter P, Shuman MA, Wu X, Atkinson JP, Wolf JL, Martin TG, Liu B. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016 Dec 01; 126(12):4640-4653.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.